Soy pinitol acts partly as an insulin sensitizer or insulin mediator in 3T3-L1 preadipocytes

Saltiel AR, Kahn CR (2001) Insulin signaling and the regulation of glucose and lipid metabolism. Nature 414:799–806

Cowherd RM, Lyle RE, McGehee RE Jr (1999) Molecular regulation of adipocyte differentiation. Cell Develop Biol 10:3–10

MacDougald OA, Mandrup S (2002) Adipogenesis forces that tip the scales. Trends Endocrinol Metab 13:5–11

Green H, Kehinde O (1974) Sublines of mouse 3T3 cells that accumulate lipid. Cell 1:113–116

Holman GD, Kasuga M (1997) From receptor to transporter: insulin signaling to glucose transport. Diabetologia 40:l001–1003

Ostlund et al (1996) United States Patent. Patent Number 5,550,166. August 277

Huang LC, Fonteles MC, Houston DB, Zhang G, Larner J (1993) Chiroinositol deficiency and insulin resistance. III. Acute glycogenic and hypoglycemic effects of two inositol phosphoglycan insulin mediators in normal and streptozotocin-diabetic rats in vivo. Endocrinology 132:652–657

Bates SH, Jones RB, Bailey CJ (2000) Insulin-like effect of pinitol. Br J Pharmacol 130:1944–1948

Campbell WW, Haub MD, Fluckey JD, Ostlund RE Jr, Thyfault JP, Morse-Carrithers H, Hulver MW, Birge ZK (2004) Pinitol supplementation does not affect insulin-mediated glucose metabolism and muscle insulin receptor content and phosphorylation in older human. J Nutr 134:2998–3003

Singh RK, Pandey BL, Tripathi M, Pandey VB (2001) Anti-inflammatory effect of (+)-pinitol. Firoterapia 72:168–170

Kim JI, Kim JC, Kang MJ, Lee MS, Kim JJ, Cha IJ (2005) Effects of pinitol isolated from soybeans on glycemic control and cardiovascular risk factors in patients with type 2 diabetes mellitus: a randomized controlled study. Eur J Clin Nutr 59:456–458

Greenwood M, Kreider RB, RasMussen C, Almada AL, Earnest CP (2001) d-Pinitol augments whole body creatine retention in man. J Exer Physiol 4:41–47

Reaven G (1995) Pathophysiology of insulin resistance in human disease. Physiol Rev 75:473–486

Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55–63

Cao Z, Umek RM, Mcknight SL (1991) Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev 5:1538–1552

Zhu Y, Qi C, Korenberg JR, Chen XN, Noya D, Rao MS, Reddy JK (1995) Structural organization of mouse peroxisome proliferators-activated receptor γ (mPPARγ) gene: altenative promoter use and different splicing yield two mPPARγ isoforms. Proc Natl Acad Sci USA 92:7921–7925

Kim JB, Spiegelman BM (1996) ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism. Genes Dev 10:1096–1107

Birkenmeier EH, Gwynn B, Howard S, Jerry J, Gordon JI, Landschulz WH, McKnight SL (1989) Tissue-specific expression, developmental regulation and genetic mapping of the gene encoding CCAAT/enhancer binding protein. Genes Dev 3:1146–1156

Christy RJ, Kaestner KH, Gelman DE, Lane MD (1991) CCAAT/enhancer binding proteins gene promoter: binding of nuclear factors during differentiation of 3T3-L1 preadipocytes. Proc Natl Acad Sci USA 88:2593–2597

Kersten S, Desvergne B, Wahli W (2000) Roles of PPARs in health and disease. Nature 405:421–424

Krempler F, Breban D, Oberkofler H, Esterbauer H, Hell E, Paulweber B, Patsch W (2000) Leptin, peroxisome proliferators-activated receptor-γ, and CCAAT/enhancer binding protein α mRNA expression in adipose tissue of humans and their relation to cardiovascular risk factors. Arterioscler Thromb Vasc Biol 20:443–449

Foretz M, Guichard C, Ferre P, Foufelle F (1999) Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related gene. Proc Natl Acad Sci USA 96:12737–12742

Maeda N, Takahashi M, Funahashi T, Kihara S, Nishizawa H, Kishida K, Nagaretani H, Matusuda M, Komuro R, Ouchi N, Kuriyama H, Hotta K, Nakamura T, Shimomura I, Matsuzawa Y (2001) PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 50:2094–2099

Sharabi Y, Oron-Herman M, Kamari Y, Avni I, Peleg E, Shabtay Z, Grossman E, Shamiss A (2007) Effect of PPAR-gamma agonist on adiponectin levels in the metabolic syndrome: lessons from the high fructose fed rat model. Am J Hyperten 20:206–210

Pajvani UB, Du X, Combs TP, Berg AH, Rajala MW, Schelthess T, Engel J, Brownlee M, Scherer PE (2003) Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications for metabolic regulation and bioactivity. J Biol Chem 278:9073–9085

Scherer PE, Williams S, Fogliani M, Baldini G, Lodish HF (1995) A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem 270:26746–26749

Shepherd PR, Kahn BB (1999) Glucose transporters and insulin action–implications for insulin resistance and diabetes mellitus. New Engl J Med 341:248–257

Czech MP (2002) Fat targets for insulin signaling. Mol Cell 9:695–696

Rosen ED, Scarraf P, Troy AE, Bradwin G, Moore K, Milstone DS, Spiegelman BM, Mortensen RM (1999) PPARγ is required for the differentiation of adipose tissue in vivo and in vitro. Mol Cell 4:611–617

Wakil S (1989) Fatty acid synthase, a proficient multifunctional enzyme. Biochemistry 28:4523–4530

Narayanan C (1987) Pinitol-a new anti-diabetic compound from the leaves of Bougainvillea. Curr Sci 56:76–78